APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

KRAS G12C Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global KRAS G12C Inhibitors Market Analysis and Forecast 2026-2032

Report ID 174006020226 December 2025199 pages

Choose your research edition.

Industry ResearchKRAS G12C Inhibitors Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal KRAS G12C Inhibitors Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal KRAS G12C Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal KRAS G12C Inhibitors Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal KRAS G12C Inhibitors Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global KRAS G12C Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for KRAS G12C Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for KRAS G12C Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for KRAS G12C Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for KRAS G12C Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of KRAS G12C Inhibitors include Innovent Biologics, Inc., Genfleet Therapeutics (Shanghai), Inc., Amgen and Mirati Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for KRAS G12C Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of KRAS G12C Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for KRAS G12C Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the KRAS G12C Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global KRAS G12C Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for KRAS G12C Inhibitors sales, projected growth trends, production technology, application and end-user industry.

KRAS G12C Inhibitors Segment by Company

Innovent Biologics, Inc.

Genfleet Therapeutics (Shanghai), Inc.

Amgen

Mirati Therapeutics

KRAS G12C Inhibitors Segment by Type

Adagrasib

Fulzerasib

Garsorasib

Sotorasib

KRAS G12C Inhibitors Segment by Application

Hospital

Clinic

Others

KRAS G12C Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global KRAS G12C Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of KRAS G12C Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of KRAS G12C Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of KRAS G12C Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of KRAS G12C Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, KRAS G12C Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global KRAS G12C Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adagrasib Major Manufacturers Table 3. Fulzerasib Major Manufacturers Table 4. Garsorasib Major Manufacturers Table 5. Sotorasib Major Manufacturers Table 6. Global KRAS G12C Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. KRAS G12C Inhibitors Industry Trends Table 11. KRAS G12C Inhibitors Industry Drivers Table 12. KRAS G12C Inhibitors Industry Opportunities and Challenges Table 13. KRAS G12C Inhibitors Industry Restraints Table 14. Global KRAS G12C Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global KRAS G12C Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 16. Global KRAS G12C Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 17. Global KRAS G12C Inhibitors Revenue Market Share by Region (2021-2026) Table 18. Global KRAS G12C Inhibitors Revenue Market Share by Region (2027-2032) Table 19. Global KRAS G12C Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global KRAS G12C Inhibitors Sales by Region (2021-2026) & (K Units) Table 21. Global KRAS G12C Inhibitors Sales by Region (2027-2032) & (K Units) Table 22. Global KRAS G12C Inhibitors Sales Market Share by Region (2021-2026) Table 23. Global KRAS G12C Inhibitors Sales Market Share by Region (2027-2032) Table 24. Global KRAS G12C Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global KRAS G12C Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 26. Global KRAS G12C Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global KRAS G12C Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 28. Global KRAS G12C Inhibitors Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global KRAS G12C Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global KRAS G12C Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global KRAS G12C Inhibitors Manufacturers, Product Type & Application Table 32. Global KRAS G12C Inhibitors Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global KRAS G12C Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global KRAS G12C Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global KRAS G12C Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 37. Global KRAS G12C Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 38. Global KRAS G12C Inhibitors Revenue Market Share by Type (2021-2026) Table 39. Global KRAS G12C Inhibitors Revenue Market Share by Type (2027-2032) Table 40. Global KRAS G12C Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units) Table 42. Global KRAS G12C Inhibitors Sales by Type (2027-2032) & (K Units) Table 43. Global KRAS G12C Inhibitors Sales Market Share by Type (2021-2026) Table 44. Global KRAS G12C Inhibitors Sales Market Share by Type (2027-2032) Table 45. Global KRAS G12C Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 46. Global KRAS G12C Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 47. Global KRAS G12C Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global KRAS G12C Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 49. Global KRAS G12C Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 50. Global KRAS G12C Inhibitors Revenue Market Share by Application (2021-2026) Table 51. Global KRAS G12C Inhibitors Revenue Market Share by Application (2027-2032) Table 52. Global KRAS G12C Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units) Table 54. Global KRAS G12C Inhibitors Sales by Application (2027-2032) & (K Units) Table 55. Global KRAS G12C Inhibitors Sales Market Share by Application (2021-2026) Table 56. Global KRAS G12C Inhibitors Sales Market Share by Application (2027-2032) Table 57. Global KRAS G12C Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 58. Global KRAS G12C Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 59. Innovent Biologics, Inc. Company Information Table 60. Innovent Biologics, Inc. Business Overview Table 61. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Innovent Biologics, Inc. KRAS G12C Inhibitors Product Portfolio Table 63. Innovent Biologics, Inc. Recent Development Table 64. Genfleet Therapeutics (Shanghai), Inc. Company Information Table 65. Genfleet Therapeutics (Shanghai), Inc. Business Overview Table 66. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Portfolio Table 68. Genfleet Therapeutics (Shanghai), Inc. Recent Development Table 69. Amgen Company Information Table 70. Amgen Business Overview Table 71. Amgen KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Amgen KRAS G12C Inhibitors Product Portfolio Table 73. Amgen Recent Development Table 74. Mirati Therapeutics Company Information Table 75. Mirati Therapeutics Business Overview Table 76. Mirati Therapeutics KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Mirati Therapeutics KRAS G12C Inhibitors Product Portfolio Table 78. Mirati Therapeutics Recent Development Table 79. North America KRAS G12C Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 80. North America KRAS G12C Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 81. North America KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units) Table 82. North America KRAS G12C Inhibitors Sales by Type (2027-2032) & (K Units) Table 83. North America KRAS G12C Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 84. North America KRAS G12C Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 85. North America KRAS G12C Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 86. North America KRAS G12C Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 87. North America KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units) Table 88. North America KRAS G12C Inhibitors Sales by Application (2027-2032) & (K Units) Table 89. North America KRAS G12C Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 90. North America KRAS G12C Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 91. North America KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America KRAS G12C Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 93. North America KRAS G12C Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 94. North America KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 95. North America KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units) Table 96. North America KRAS G12C Inhibitors Sales by Country (2027-2032) & (K Units) Table 97. North America KRAS G12C Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 98. North America KRAS G12C Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 99. United States KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 100. Canada KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 101. Mexico KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 102. Europe KRAS G12C Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe KRAS G12C Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units) Table 105. Europe KRAS G12C Inhibitors Sales by Type (2027-2032) & (K Units) Table 106. Europe KRAS G12C Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 107. Europe KRAS G12C Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 108. Europe KRAS G12C Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe KRAS G12C Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units) Table 111. Europe KRAS G12C Inhibitors Sales by Application (2027-2032) & (K Units) Table 112. Europe KRAS G12C Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 113. Europe KRAS G12C Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 114. Europe KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe KRAS G12C Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe KRAS G12C Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. Europe KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units) Table 119. Europe KRAS G12C Inhibitors Sales by Country (2027-2032) & (K Units) Table 120. Europe KRAS G12C Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 121. Europe KRAS G12C Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 122. Germany KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 123. France KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 124. U.K. KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 125. Italy KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 126. Russia KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 127. Spain KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 128. Netherlands KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 129. Switzerland KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 130. Sweden KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 131. Poland KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 132. China KRAS G12C Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 133. China KRAS G12C Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 134. China KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units) Table 135. China KRAS G12C Inhibitors Sales by Type (2027-2032) & (K Units) Table 136. China KRAS G12C Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 137. China KRAS G12C Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 138. China KRAS G12C Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 139. China KRAS G12C Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 140. China KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units) Table 141. China KRAS G12C Inhibitors Sales by Application (2027-2032) & (K Units) Table 142. China KRAS G12C Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 143. China KRAS G12C Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia KRAS G12C Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia KRAS G12C Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units) Table 147. Asia KRAS G12C Inhibitors Sales by Type (2027-2032) & (K Units) Table 148. Asia KRAS G12C Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Asia KRAS G12C Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Asia KRAS G12C Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia KRAS G12C Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units) Table 153. Asia KRAS G12C Inhibitors Sales by Application (2027-2032) & (K Units) Table 154. Asia KRAS G12C Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Asia KRAS G12C Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia KRAS G12C Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia KRAS G12C Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Asia KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units) Table 161. Asia KRAS G12C Inhibitors Sales by Country (2027-2032) & (K Units) Table 162. Asia KRAS G12C Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Asia KRAS G12C Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Japan KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 165. South Korea KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 166. India KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 167. Australia KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 168. Taiwan KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 170. SAMEA KRAS G12C Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA KRAS G12C Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units) Table 173. SAMEA KRAS G12C Inhibitors Sales by Type (2027-2032) & (K Units) Table 174. SAMEA KRAS G12C Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 175. SAMEA KRAS G12C Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 176. SAMEA KRAS G12C Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA KRAS G12C Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units) Table 179. SAMEA KRAS G12C Inhibitors Sales by Application (2027-2032) & (K Units) Table 180. SAMEA KRAS G12C Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 181. SAMEA KRAS G12C Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 182. SAMEA KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA KRAS G12C Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA KRAS G12C Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. SAMEA KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units) Table 187. SAMEA KRAS G12C Inhibitors Sales by Country (2027-2032) & (K Units) Table 188. SAMEA KRAS G12C Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 189. SAMEA KRAS G12C Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Brazil KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 191. Argentina KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 192. Chile KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 193. Colombia KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 194. Peru KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 196. Israel KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 197. UAE KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 198. Turkey KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 199. Iran KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 200. Egypt KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. KRAS G12C Inhibitors Distributors List Table 204. KRAS G12C Inhibitors Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. KRAS G12C Inhibitors Image Figure 2. Global KRAS G12C Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global KRAS G12C Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adagrasib Image Figure 5. Fulzerasib Image Figure 6. Garsorasib Image Figure 7. Sotorasib Image Figure 8. Global KRAS G12C Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global KRAS G12C Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global KRAS G12C Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global KRAS G12C Inhibitors Revenue (2021-2032) & (US$ Million) Figure 15. Global KRAS G12C Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global KRAS G12C Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global KRAS G12C Inhibitors Revenue Market Share by Region (2021-2032) Figure 18. Global KRAS G12C Inhibitors Sales (2021-2032) & (K Units) Figure 19. Global KRAS G12C Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global KRAS G12C Inhibitors Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico KRAS G12C Inhibitors Sales YoY (2021-2032) & (K Units) Figure 22. Europe KRAS G12C Inhibitors Sales YoY (2021-2032) & (K Units) Figure 23. China KRAS G12C Inhibitors Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) KRAS G12C Inhibitors Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa KRAS G12C Inhibitors Sales YoY (2021-2032) & (K Units) Figure 26. Global KRAS G12C Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global KRAS G12C Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global KRAS G12C Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global KRAS G12C Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global KRAS G12C Inhibitors Revenue Market Share by Type (2021-2032) Figure 32. Global KRAS G12C Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global KRAS G12C Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global KRAS G12C Inhibitors Sales Market Share by Type (2021-2032) Figure 35. Global KRAS G12C Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global KRAS G12C Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global KRAS G12C Inhibitors Revenue Market Share by Application (2021-2032) Figure 38. Global KRAS G12C Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global KRAS G12C Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global KRAS G12C Inhibitors Sales Market Share by Application (2021-2032) Figure 41. North America KRAS G12C Inhibitors Revenue Share by Type (2021-2032) Figure 42. North America KRAS G12C Inhibitors Sales Share by Type (2021-2032) Figure 43. North America KRAS G12C Inhibitors Revenue Share by Application (2021-2032) Figure 44. North America KRAS G12C Inhibitors Sales Share by Application (2021-2032) Figure 45. North America KRAS G12C Inhibitors Revenue Share by Country (2021-2032) Figure 46. North America KRAS G12C Inhibitors Sales Share by Country (2021-2032) Figure 47. Europe KRAS G12C Inhibitors Revenue Share by Type (2021-2032) Figure 48. Europe KRAS G12C Inhibitors Sales Share by Type (2021-2032) Figure 49. Europe KRAS G12C Inhibitors Revenue Share by Application (2021-2032) Figure 50. Europe KRAS G12C Inhibitors Sales Share by Application (2021-2032) Figure 51. Europe KRAS G12C Inhibitors Revenue Share by Country (2021-2032) Figure 52. Europe KRAS G12C Inhibitors Sales Share by Country (2021-2032) Figure 53. China KRAS G12C Inhibitors Revenue Share by Type (2021-2032) Figure 54. China KRAS G12C Inhibitors Sales Share by Type (2021-2032) Figure 55. China KRAS G12C Inhibitors Revenue Share by Application (2021-2032) Figure 56. China KRAS G12C Inhibitors Sales Share by Application (2021-2032) Figure 57. Asia KRAS G12C Inhibitors Revenue Share by Type (2021-2032) Figure 58. Asia KRAS G12C Inhibitors Sales Share by Type (2021-2032) Figure 59. Asia KRAS G12C Inhibitors Revenue Share by Application (2021-2032) Figure 60. Asia KRAS G12C Inhibitors Sales Share by Application (2021-2032) Figure 61. Asia KRAS G12C Inhibitors Revenue Share by Country (2021-2032) Figure 62. Asia KRAS G12C Inhibitors Sales Share by Country (2021-2032) Figure 63. SAMEA KRAS G12C Inhibitors Revenue Share by Type (2021-2032) Figure 64. SAMEA KRAS G12C Inhibitors Sales Share by Type (2021-2032) Figure 65. SAMEA KRAS G12C Inhibitors Revenue Share by Application (2021-2032) Figure 66. SAMEA KRAS G12C Inhibitors Sales Share by Application (2021-2032) Figure 67. SAMEA KRAS G12C Inhibitors Revenue Share by Country (2021-2032) Figure 68. SAMEA KRAS G12C Inhibitors Sales Share by Country (2021-2032) Figure 69. KRAS G12C Inhibitors Value Chain Figure 70. Manufacturing Cost Structure Figure 71. KRAS G12C Inhibitors Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Adagrasib
  • Fulzerasib
  • Garsorasib
  • Sotorasib
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Innovent Biologics, Inc.
  • Genfleet Therapeutics (Shanghai), Inc.
  • Amgen
  • Mirati Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 KRAS G12C Inhibitors Market by Type
  3. 1.2.1 Global KRAS G12C Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adagrasib
  5. 1.2.3 Fulzerasib
  6. 1.2.4 Garsorasib
  7. 1.2.5 Sotorasib
  8. 1.3 KRAS G12C Inhibitors Market by Application
  9. 1.3.1 Global KRAS G12C Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 KRAS G12C Inhibitors Market Dynamics
  1. 2.1 KRAS G12C Inhibitors Industry Trends
  2. 2.2 KRAS G12C Inhibitors Industry Drivers
  3. 2.3 KRAS G12C Inhibitors Industry Opportunities and Challenges
  4. 2.4 KRAS G12C Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global KRAS G12C Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global KRAS G12C Inhibitors Revenue by Region
  3. 3.2.1 Global KRAS G12C Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global KRAS G12C Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global KRAS G12C Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global KRAS G12C Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global KRAS G12C Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global KRAS G12C Inhibitors Sales by Region
  9. 3.4.1 Global KRAS G12C Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global KRAS G12C Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global KRAS G12C Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global KRAS G12C Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global KRAS G12C Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global KRAS G12C Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global KRAS G12C Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global KRAS G12C Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global KRAS G12C Inhibitors Sales by Manufacturers
  6. 4.2.1 Global KRAS G12C Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global KRAS G12C Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global KRAS G12C Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global KRAS G12C Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global KRAS G12C Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global KRAS G12C Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global KRAS G12C Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global KRAS G12C Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global KRAS G12C Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 KRAS G12C Inhibitors Tier 1, Tier 2, and Tier 3
5 KRAS G12C Inhibitors Market by Type
  1. 5.1 Global KRAS G12C Inhibitors Revenue by Type
  2. 5.1.1 Global KRAS G12C Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global KRAS G12C Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global KRAS G12C Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global KRAS G12C Inhibitors Sales by Type
  6. 5.2.1 Global KRAS G12C Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global KRAS G12C Inhibitors Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global KRAS G12C Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global KRAS G12C Inhibitors Price by Type
6 KRAS G12C Inhibitors Market by Application
  1. 6.1 Global KRAS G12C Inhibitors Revenue by Application
  2. 6.1.1 Global KRAS G12C Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global KRAS G12C Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global KRAS G12C Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global KRAS G12C Inhibitors Sales by Application
  6. 6.2.1 Global KRAS G12C Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global KRAS G12C Inhibitors Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global KRAS G12C Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global KRAS G12C Inhibitors Price by Application
7 Company Profiles
  1. 7.1 Innovent Biologics, Inc.
  2. 7.1.1 Innovent Biologics, Inc. Company Information
  3. 7.1.2 Innovent Biologics, Inc. Business Overview
  4. 7.1.3 Innovent Biologics, Inc. KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Portfolio
  6. 7.1.5 Innovent Biologics, Inc. Recent Developments
  7. 7.2 Genfleet Therapeutics (Shanghai), Inc.
  8. 7.2.1 Genfleet Therapeutics (Shanghai), Inc. Company Information
  9. 7.2.2 Genfleet Therapeutics (Shanghai), Inc. Business Overview
  10. 7.2.3 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Portfolio
  12. 7.2.5 Genfleet Therapeutics (Shanghai), Inc. Recent Developments
  13. 7.3 Amgen
  14. 7.3.1 Amgen Company Information
  15. 7.3.2 Amgen Business Overview
  16. 7.3.3 Amgen KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amgen KRAS G12C Inhibitors Product Portfolio
  18. 7.3.5 Amgen Recent Developments
  19. 7.4 Mirati Therapeutics
  20. 7.4.1 Mirati Therapeutics Company Information
  21. 7.4.2 Mirati Therapeutics Business Overview
  22. 7.4.3 Mirati Therapeutics KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mirati Therapeutics KRAS G12C Inhibitors Product Portfolio
  24. 7.4.5 Mirati Therapeutics Recent Developments
8 North America
  1. 8.1 North America KRAS G12C Inhibitors Market Size by Type
  2. 8.1.1 North America KRAS G12C Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America KRAS G12C Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America KRAS G12C Inhibitors Price by Type (2021-2032)
  5. 8.2 North America KRAS G12C Inhibitors Market Size by Application
  6. 8.2.1 North America KRAS G12C Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America KRAS G12C Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America KRAS G12C Inhibitors Price by Application (2021-2032)
  9. 8.3 North America KRAS G12C Inhibitors Market Size by Country
  10. 8.3.1 North America KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America KRAS G12C Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe KRAS G12C Inhibitors Market Size by Type
  2. 9.1.1 Europe KRAS G12C Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe KRAS G12C Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe KRAS G12C Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe KRAS G12C Inhibitors Market Size by Application
  6. 9.2.1 Europe KRAS G12C Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe KRAS G12C Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe KRAS G12C Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe KRAS G12C Inhibitors Market Size by Country
  10. 9.3.1 Europe KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe KRAS G12C Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China KRAS G12C Inhibitors Market Size by Type
  2. 10.1.1 China KRAS G12C Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China KRAS G12C Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China KRAS G12C Inhibitors Price by Type (2021-2032)
  5. 10.2 China KRAS G12C Inhibitors Market Size by Application
  6. 10.2.1 China KRAS G12C Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China KRAS G12C Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China KRAS G12C Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia KRAS G12C Inhibitors Market Size by Type
  2. 11.1.1 Asia KRAS G12C Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia KRAS G12C Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia KRAS G12C Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia KRAS G12C Inhibitors Market Size by Application
  6. 11.2.1 Asia KRAS G12C Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia KRAS G12C Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia KRAS G12C Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia KRAS G12C Inhibitors Market Size by Country
  10. 11.3.1 Asia KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia KRAS G12C Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA KRAS G12C Inhibitors Market Size by Type
  2. 12.1.1 SAMEA KRAS G12C Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA KRAS G12C Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA KRAS G12C Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA KRAS G12C Inhibitors Market Size by Application
  6. 12.2.1 SAMEA KRAS G12C Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA KRAS G12C Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA KRAS G12C Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA KRAS G12C Inhibitors Market Size by Country
  10. 12.3.1 SAMEA KRAS G12C Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA KRAS G12C Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA KRAS G12C Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 KRAS G12C Inhibitors Value Chain Analysis
  2. 13.1.1 KRAS G12C Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 KRAS G12C Inhibitors Production Mode & Process
  6. 13.2 KRAS G12C Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 KRAS G12C Inhibitors Distributors
  9. 13.2.3 KRAS G12C Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst